Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2021-09-14 15:46:09 UTC |
---|
HMDB ID | HMDB0000982 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 5-Methylcytidine |
---|
Description | 5-Methylcytidine belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. 5-Methylcytidine has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make 5-methylcytidine a potential biomarker for the consumption of these foods. Based on a literature review a significant number of articles have been published on 5-Methylcytidine. |
---|
Structure | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N=C1N InChI=1S/C10H15N3O5/c1-4-2-13(10(17)12-8(4)11)9-7(16)6(15)5(3-14)18-9/h2,5-7,9,14-16H,3H2,1H3,(H2,11,12,17)/t5-,6-,7-,9-/m1/s1 |
---|
Synonyms | Value | Source |
---|
5-Methyl-cytidine | HMDB | 5-Methylcytidine | HMDB |
|
---|
Chemical Formula | C10H15N3O5 |
---|
Average Molecular Weight | 257.2432 |
---|
Monoisotopic Molecular Weight | 257.101170605 |
---|
IUPAC Name | 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one |
---|
Traditional Name | 5-methylcytidine |
---|
CAS Registry Number | 2140-61-6 |
---|
SMILES | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N=C1N |
---|
InChI Identifier | InChI=1S/C10H15N3O5/c1-4-2-13(10(17)12-8(4)11)9-7(16)6(15)5(3-14)18-9/h2,5-7,9,14-16H,3H2,1H3,(H2,11,12,17)/t5-,6-,7-,9-/m1/s1 |
---|
InChI Key | ZAYHVCMSTBRABG-JXOAFFINSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Nucleosides, nucleotides, and analogues |
---|
Class | Pyrimidine nucleosides |
---|
Sub Class | Not Available |
---|
Direct Parent | Pyrimidine nucleosides |
---|
Alternative Parents | |
---|
Substituents | - Pyrimidine nucleoside
- Glycosyl compound
- N-glycosyl compound
- Pentose monosaccharide
- Hydroxypyrimidine
- Hydropyrimidine
- Monosaccharide
- Pyrimidine
- Tetrahydrofuran
- Heteroaromatic compound
- Secondary alcohol
- Organoheterocyclic compound
- Azacycle
- Oxacycle
- Organic nitrogen compound
- Hydrocarbon derivative
- Primary alcohol
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Alcohol
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 213 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | -2.01 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
5-Methylcytidine,1TMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O)C(=O)N=C1N | 2477.7 | Semi standard non polar | 33892256 | 5-Methylcytidine,1TMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O)C(=O)N=C1N | 2481.8 | Semi standard non polar | 33892256 | 5-Methylcytidine,1TMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C)C(=O)N=C1N | 2468.8 | Semi standard non polar | 33892256 | 5-Methylcytidine,1TMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N=C1N[Si](C)(C)C | 2535.8 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O)C(=O)N=C1N | 2467.9 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C)C(=O)N=C1N | 2464.9 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O)C(=O)N=C1N[Si](C)(C)C | 2492.8 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N | 2467.7 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TMS,isomer #5 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O)C(=O)N=C1N[Si](C)(C)C | 2507.1 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TMS,isomer #6 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C)C(=O)N=C1N[Si](C)(C)C | 2504.2 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TMS,isomer #7 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2489.5 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N | 2454.3 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O)C(=O)N=C1N[Si](C)(C)C | 2489.0 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C)C(=O)N=C1N[Si](C)(C)C | 2492.9 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2464.8 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TMS,isomer #5 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N[Si](C)(C)C | 2482.3 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TMS,isomer #6 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2461.2 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TMS,isomer #7 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2461.1 | Semi standard non polar | 33892256 | 5-Methylcytidine,4TMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N[Si](C)(C)C | 2507.5 | Semi standard non polar | 33892256 | 5-Methylcytidine,4TMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N[Si](C)(C)C | 2564.4 | Standard non polar | 33892256 | 5-Methylcytidine,4TMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N[Si](C)(C)C | 3016.6 | Standard polar | 33892256 | 5-Methylcytidine,4TMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2489.9 | Semi standard non polar | 33892256 | 5-Methylcytidine,4TMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2623.6 | Standard non polar | 33892256 | 5-Methylcytidine,4TMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2885.6 | Standard polar | 33892256 | 5-Methylcytidine,4TMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2498.3 | Semi standard non polar | 33892256 | 5-Methylcytidine,4TMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2634.6 | Standard non polar | 33892256 | 5-Methylcytidine,4TMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2929.0 | Standard polar | 33892256 | 5-Methylcytidine,4TMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2486.0 | Semi standard non polar | 33892256 | 5-Methylcytidine,4TMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2628.7 | Standard non polar | 33892256 | 5-Methylcytidine,4TMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2859.1 | Standard polar | 33892256 | 5-Methylcytidine,5TMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2532.5 | Semi standard non polar | 33892256 | 5-Methylcytidine,5TMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2617.3 | Standard non polar | 33892256 | 5-Methylcytidine,5TMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2714.2 | Standard polar | 33892256 | 5-Methylcytidine,1TBDMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O)C(=O)N=C1N | 2749.7 | Semi standard non polar | 33892256 | 5-Methylcytidine,1TBDMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C(=O)N=C1N | 2737.5 | Semi standard non polar | 33892256 | 5-Methylcytidine,1TBDMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N | 2733.5 | Semi standard non polar | 33892256 | 5-Methylcytidine,1TBDMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 2787.2 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TBDMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C(=O)N=C1N | 2940.6 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TBDMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N | 2940.4 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TBDMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 2973.0 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TBDMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N | 2926.7 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TBDMS,isomer #5 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 2968.8 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TBDMS,isomer #6 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 2952.7 | Semi standard non polar | 33892256 | 5-Methylcytidine,2TBDMS,isomer #7 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2944.6 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TBDMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N | 3151.1 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TBDMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3171.0 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TBDMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3176.7 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TBDMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3144.6 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TBDMS,isomer #5 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3161.3 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TBDMS,isomer #6 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3158.0 | Semi standard non polar | 33892256 | 5-Methylcytidine,3TBDMS,isomer #7 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3144.0 | Semi standard non polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3348.3 | Semi standard non polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3320.5 | Standard non polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3363.6 | Standard polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3349.1 | Semi standard non polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3375.0 | Standard non polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #2 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3222.2 | Standard polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3356.8 | Semi standard non polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3387.2 | Standard non polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #3 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3256.5 | Standard polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3344.4 | Semi standard non polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3374.1 | Standard non polar | 33892256 | 5-Methylcytidine,4TBDMS,isomer #4 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3204.0 | Standard polar | 33892256 | 5-Methylcytidine,5TBDMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3538.6 | Semi standard non polar | 33892256 | 5-Methylcytidine,5TBDMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3490.8 | Standard non polar | 33892256 | 5-Methylcytidine,5TBDMS,isomer #1 | CC1=CN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3189.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0adl-9420000000-0b05b3fff49a937e78cb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (3 TMS) - 70eV, Positive | splash10-001i-6921100000-895058c6ba83f084d86e | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_3_5) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_3_6) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TMS_3_7) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methylcytidine GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-004i-0900000000-01346f227c58c4e64dd3 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-004i-0900000000-25d8b3fb44e47bc7f544 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-004i-1900000000-0ad90898ddb462fa200b | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine 40V, Positive-QTOF | splash10-004i-4900000000-ff34d9c361d96f5aa2de | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine 20V, Positive-QTOF | splash10-004i-0900000000-0366c638ef303f3731b3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine 35V, Positive-QTOF | splash10-004i-0900000000-f936466105072c9b573c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine 10V, Positive-QTOF | splash10-056r-0950000000-10971ba54196bbfdfc8d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine 10V, Negative-QTOF | splash10-0a4i-0090000000-d8be738cdc4e54477227 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine 35V, Negative-QTOF | splash10-0gi0-1490000000-f34a1cb7ce97d538cb7a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine 20V, Negative-QTOF | splash10-0avi-1960000000-da3e8a4eb805781bcbc6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 5-Methylcytidine 40V, Negative-QTOF | splash10-0002-9000000000-0a9ca0be7ac354db9478 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 10V, Positive-QTOF | splash10-004i-0910000000-960e39cedc554f014863 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 20V, Positive-QTOF | splash10-004i-2900000000-2ecbb224dc501d648886 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 40V, Positive-QTOF | splash10-056r-5900000000-55a400dd7cd5fcd9ea3d | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 10V, Negative-QTOF | splash10-00di-0950000000-0275ab78e34a521999fb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 20V, Negative-QTOF | splash10-00di-3920000000-50690663d91d4d14a39c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 40V, Negative-QTOF | splash10-007p-9200000000-978b587a0b7b22774839 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 10V, Negative-QTOF | splash10-0ab9-0890000000-24f0c238f60d3c00adbb | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 20V, Negative-QTOF | splash10-006y-9700000000-c0edbd46e86d76296c58 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 40V, Negative-QTOF | splash10-0005-9200000000-9358476776cf6eec42c1 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 10V, Positive-QTOF | splash10-004i-0900000000-a1c51dd1d9ae2dee6e38 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 20V, Positive-QTOF | splash10-004i-1910000000-f366741e71fc5efb780d | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methylcytidine 40V, Positive-QTOF | splash10-0a7i-8900000000-f063ff1fc5cb2b980e9e | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Disease References | Crohn's disease |
---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
| Iron deficiency |
---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
|
|
---|